Biogen Receives Positive CHMP Opinion for TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®GlobeNewsWire • 04/25/24
Biogen (BIIB) Q1 Earnings Beat, Stock Up on Alzheimer Drug UptakeZacks Investment Research • 04/24/24
Biogen first-quarter profit tops estimates as Alzheimer's drug uptake improvesMarket Watch • 04/24/24
Biogen tops quarterly profit estimates as cost cuts take hold, Leqembi launch picks upCNBC • 04/24/24
Two Notable Biogen Drugs Walloped Sales Forecasts. Will It Be Enough To Reverse Biogen Stock's Decline?Investors Business Daily • 04/24/24
Gear Up for Biogen (BIIB) Q1 Earnings: Wall Street Estimates for Key MetricsZacks Investment Research • 04/19/24
Biogen Inc. (BIIB) Falls More Steeply Than Broader Market: What Investors Need to KnowZacks Investment Research • 04/01/24
Indivi to Collaborate with Biogen to Advance Digital Health Technology and Digital Biomarkers for Parkinson's DiseaseBusiness Wire • 03/26/24
Biogen Inc. (BIIB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsBusiness Wire • 03/21/24
Biogen Inc. (BIIB) Stock Falls Amid Market Uptick: What Investors Need to KnowZacks Investment Research • 03/12/24
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Biogen Inc. - BIIBPRNewsWire • 03/11/24